Top Healthcare Stocks
Healthcare stocks came in to Thursday's selloff for stocks with
the NYSE Healthcare Sector Index falling 1.5% and shares of
healthcare companies in the S&P 500 declining 1.3% as a
In company news,Venaxis Inc. (
) shares advanced to some of their best prices in nearly two years
after the in-vitro diagnostics company issued positive top-line
results from Phase III testing of its trademarked APPY1 test.
The APPY1 test already has been cleared for use in the European
Union and is designed to identify patient with a low risk for
appendicitis using a multiple rapid biomarker-based assay.
According to the company, the test performed well, with
sensitivity and negative predictive value results exceeding results
from a previous pilot study. APPY plans to include the test results
in its application for 510(k) device clearance from the U.S. Food
and Drug Administration, expected to be filed within the next few
APPY share were up 21.7% at $3.30 apiece in recent trade,
earlier climbing to an intra-day higher of $3.88, matching its best
levels since late April 2011.
In other sector news,
(+) LPHI, Shares spike after a federal jury in Texas rules the
Securities and Exchange Commission failed to prove any of its fraud
claims against the life-settlements company, CEO Brian Pardo and
its general counsel, Scott Peden.
(-) CYTX, Revenue declines 52% year over year to $3.5 mln.
Swings to $0.14 per share net loss from $0.06 per share profit last
year. Analyst estimates were not available for comparison.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.